EC Number |
Inhibitors |
Structure |
---|
4.1.1.23 | (5-(4-amino-3-oxido-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl)-methyl dihydrogen phosphate |
i.e. CMP-N3-oxide |
|
4.1.1.23 | 1-(5'-phospho-beta-D-ribofuranosyl)barbituric acid |
reversible |
|
4.1.1.23 | 1-(5'-phospho-beta-D-ribofuranosyl)barbituric acid |
- |
|
4.1.1.23 | 1-(5'-phospho-beta-D-ribofuranosyl)barbituric acid |
high affinity inhibitor |
|
4.1.1.23 | 1-(5'-phospho-beta-D-ribofuranosyl)barbituric acid |
mode of binding |
|
4.1.1.23 | 1-methylorotate |
modeling of binding and structure |
|
4.1.1.23 | 1-Ribosyloxipurinol 5'-phosphate |
most effective oxipurinol nucleotide inhibitor |
|
4.1.1.23 | 1-Ribosyloxipurinol 5'-phosphate |
- |
|
4.1.1.23 | 2'-deoxy-2'-fluoro-6-iodo-beta-D-uridine 5'-O-monophosphate |
- |
|
4.1.1.23 | 2'-deoxy-2'-fluoro-6-iodo-UMP |
- |
|